Last update 08 May 2025

Aurora B x FLT3 x PKC

Basic Info

Related Targets
Aurora BFLT3PKC

Related

1
Drugs associated with Aurora B x FLT3 x PKC
GO-6976
Target
Aurora B x FLT3 x PKC
Mechanism
Aurora B inhibitors [+2]
Active Org.
University of FukuiUniversity of Fukui
Originator Org.
Gödecke GmbH
Active Indication
Acute Myeloid Leukemia with FLT3/ITD Mutation
Inactive Indication
Inflammation
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
100 Clinical Results associated with Aurora B x FLT3 x PKC
Login to view more data
100 Translational Medicine associated with Aurora B x FLT3 x PKC
Login to view more data
0 Patents (Medical) associated with Aurora B x FLT3 x PKC
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free